Exelixis Clinical Site #56
Porto 4099-001
0 studies enrolling now ยท 1 studies all time
What they study most
Metastatic Prostate Cancer, Prostate Adenocarcinoma
Studies at this site
- Study of Cabozantinib in Combination With Atezolizumab Versus Second NHT in Subjects With mCRPC โ Running, not enrolling